CHMP recommends eight new drug approvals, six label expansions
It was a positive week for the European Medicines Agency’s human medicines committee (CHMP), which recommended the approval of eight new drugs including Takeda’s Fruzaqla and AstraZeneca’s Truqap.
The committee also voted in favor of six new label expansions. While the European Commission has the final authority over new drug approvals, it typically follows CHMP’s recommendations.
The approval recommendations include:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
